首页 > 市场调查报告书 > 医疗设备

心血管设备

市场调查报告书

商品编码

1522918

全球心臟定位市场规模、份额和成长分析：按产品、按适应症、按最终用户、按地区 - 行业预测，2024-2031 年

Global Cardiac Mapping Market Size, Share, Growth Analysis, By Product, By Indication, By End User, By Region - Industry Forecast 2024-2031

出版日期: 2024年07月14日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2022年全球心臟定位市场规模将为18.6亿美元，从2023年的20.3亿美元增长到2031年的40.1亿美元，预计在预测期内（2024-2031年）增长。 %）。

根据心律协会的报告，大约有 1,400 万美国人患有心律不整。为了解决这个普遍存在的问题，全球心臟定位系统提供了一种非侵入性的先进评估方法。该技术可捕捉胸部的电脉衝，并将其与电脑断层扫描的资料结合，创建详细的心臟图。这些图表对于专家彻底分析心律模式至关重要。透过利用心臟定位，医疗保健专业人员可以提高对这些疾病的了解，从而获得更准确的诊断和个人化的治疗计划，最终改善患者的治疗效果。

市场概况
北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲国家地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲 (MEA)
- 海湾合作委员会国家
- 南非
- 其他中东/非洲地区

竞争格局

前5名企业对比
主要企业市场定位（2023年）
主要市场参与者所采取的策略
近期市集活动
主要企业市场占有率（2023年）

主要企业简介

Biosense Webster（US）
Abbott（US）
Boston Scientific Corporation（US）
Medtronic（Ireland）
MicroPort Scientific Corporation（China）
EP Solutions（Switzerland）

Acutus Medical Inc.（美国）

公司简介
业务部门概览
财务更新
主要进展

Koninklijke Philips NV (Netherlands)
- 公司简介
- 业务部门概览
- 财务更新
- 主要进展
Lepu Medical Technology Co. Ltd. (China)
- 公司简介
- 业务部门概览
- 财务更新
- 主要进展
BIOTRONIK (Germany)
- 公司简介
- 业务部门概览
- 财务更新
- 主要进展
AngioDynamics (US)
- 公司简介
- 业务部门概览
- 财务更新
- 主要进展
BioSig Technologies (US)
- 公司简介
- 业务部门概览
- 财务更新
- 主要进展
APN Health (US)
- 公司简介
- 业务部门概览
- 财务更新
- 主要进展
CoreMap (US)
- 公司简介
- 业务部门概览
- 财务更新
- 主要进展
Kardium (Canada)
- 公司简介
- 业务部门概览
- 财务更新
- 主要进展
Catheter Precision (US)
- 公司简介
- 业务部门概览
- 财务更新
- 主要进展
Epmap-System (Germany)
- 公司简介
- 业务部门概览
- 财务更新
- 主要进展

简介目录

Product Code: SQMIG35A2783

Global Cardiac Mapping Market size was valued at USD 1.86 billion in 2022 and is poised to grow from USD 2.03 billion in 2023 to USD 4.01 billion by 2031, growing at a CAGR of 8.9% in the forecast period (2024-2031).

The Heart Rhythm Society reports that around 14 million Americans suffer from heart rhythm disorders. Addressing this widespread issue, cardiac mapping systems offer a non-invasive, advanced method for assessment. This technique captures electrical impulses from the chest and integrates them with CT scan data to create detailed cardiac maps. These maps are crucial for specialists to thoroughly analyze heart rhythm patterns. By leveraging cardiac mapping, healthcare professionals can enhance their understanding of these disorders, leading to more accurate diagnoses and personalized treatment plans, ultimately improving patient outcomes.

Top-down and bottom-up approaches were used to estimate and validate the size of the Cardiac Mapping market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Cardiac Mapping Market Segmental Analysis

The Cardiac Mapping Market is segmented on the basis of type, indication, end user, and region. Based on type, the market is segmented into Contact Cardiac Mapping Systems (Electroanatomical Mapping Systems, Basket Catheter Mapping Systems, Traditional Endocardial Catheter Mapping Systems), and Non-Contact Cardiac Mapping Systems. Based on indication, the market is segmented into Atrial Fibrillation, Atrial Flutter, AVNRT, and Others. Based on end user, the market is segmented into Hospitals & Clinics, Diagnostic Centers, and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Drivers of the Cardiac Mapping Market

The expected rise in market revenue for cardiac mapping systems is driven by the increasing prevalence of cardiovascular disorders and ongoing advancements in diagnostic technology. The World Health Organization (WHO) reports that cardiovascular diseases (CVDs) are the foremost cause of death worldwide, accounting for about 17.9 million deaths each year. Remarkably, over 80% of these fatalities are due to heart attacks and strokes, with a substantial number affecting people younger than 70. This surge in CVD cases, coupled with innovations in cardiac mapping diagnostics, underscores the growing demand for more sophisticated and effective cardiac mapping systems.

Restraints in the Cardiac Mapping Market

The cardiac mapping market faces a significant challenge due to the complexity of cardiac mapping procedures, which hampers revenue growth by limiting adoption and accessibility. However, this obstacle is countered by advancements in modern electro-anatomical mapping systems, cutting-edge electrophysiology catheters, and improved cardiac imaging technologies. These innovations have enriched the toolkit for healthcare professionals, allowing for a broader array of mapping strategies and techniques in electrophysiology procedures, thus fostering the market's growth. The integration of these technologies enhances procedural efficacy, mitigates the inherent complexities, and promotes more widespread utilization of cardiac mapping methods.

Market Trends of the Cardiac Mapping Market

The cardiac mapping market is projected to experience significant growth during the forecast period, propelled by various factors. Key among these is the pivotal role of medical device companies, which are increasingly incorporating advanced diagnostic technologies. This trend is driven by the rising demand for accurate cardiac disease diagnosis, underscoring the importance of innovative solutions for managing complex cardiac conditions. Additionally, the market expansion is bolstered by the growing availability of interventional cardiologists with specialized training, particularly in developing economies, thereby enhancing the overall accessibility and application of advanced cardiac mapping techniques.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Technology Analysis
Value Chain Analysis
Start Up Analysis
Regulatory Landscape
Patent Analysis
Key Success Factors
Market Attractiveness Index
Degree of Competition
Top Investment Pockets
Ecosystem Mapping

Cardiac Mapping Market by Product

Market Overview
Contact Cardiac Mapping Systems
- Electroanatomical Mapping Systems
- Basket Catheter Mapping Systems
- Traditional Endocardial Catheter Mapping Systems
Non-Contact Cardiac Mapping Systems

Cardiac Mapping Market by Indication

Market Overview
Atrial Fibrillation
Atrial Flutter
AVNRT
Others

Cardiac Mapping Market by End User

Market Overview
Hospitals & Clinics
Diagnostic Centers
Others

Cardiac Mapping Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Biosense Webster (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Scientific Corporation (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MicroPort Scientific Corporation (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
EP Solutions (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments

Acutus Medical Inc. (U.S.)

Company Overview
Business Segment Overview
Financial Updates
Key Developments

Koninklijke Philips N.V. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lepu Medical Technology Co. Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BIOTRONIK (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AngioDynamics (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioSig Technologies (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
APN Health (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CoreMap (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Kardium (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Catheter Precision (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Epmap-System (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments